Clinical trial
Evaluation of the Efficacy and Safety of Eye Drops With Hyaluronic Acid Sodium Salt 0.30% and Amino Acid (BLUgel A Free) in Patients With Moderate to Severe Dry Eye Syndrome and Hyaluronic Acid Sodium Salt 0.15% and Amino Acid (BLUyal A Free) in Patients With Mild Dry Eye Syndrome
NCT06189456 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of Eye Drops With Hyaluronic Acid Sodium Salt 0.30% and Amino Acid (BLUgel A Free) in Patients With Moderate to Severe Dry Eye Syndrome and Hyaluronic Acid Sodium Salt 0.15% and Amino Acid (BLUyal A Free) in Patients With Mild Dry Eye Syndrome
- Lead sponsor
- Fidia Farmaceutici s.p.a.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 21, 2023
- Completion date
- December 4, 2024
- Enrollment
- 101 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye syndrome (des)